Actinium Pharmaceuticals Inc (ATNM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ATNM | GALT | PRLD | ||
| Company | Actinium Pharmaceuticals Inc | Galectin Therapeutic | Prelude Therapeutics Inc | ||
| Price Information | |||||
| Exchange | NYSE Arca | NASDAQ | NASDAQ | ||
| Open | 7.31 | 3.56 | 3.84 | ||
| High | 7.98 | 3.67 | 3.86 | ||
| Low | 7.31 | 3.43 | 3.56 | ||
| Last | 7.70 | 3.51 | 3.77 | ||
| Change | +0.32 | -0.09 | -0.07 | ||
| % Change | +4.34% | -2.50% | -1.82% | ||
| Volume | 282,600 | 148,700 | 48,400 | ||
| 20-Day Average Volume | 322,815 | 322,710 | 47,350 | ||
| Previous Close | 7.38 | 3.60 | 3.84 | ||
| Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
| Has Options | Yes | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 7.97 | 3.52 | 4.44 | ||
| 20-Day Raw Stochastic | 38.32% | 58.06% | 14.52% | ||
| 20-Day Relative Strength | 50.83% | 59.87% | 42.54% | ||
| Weighted Alpha | -14.67 | +72.10 | -45.42 | ||
| Today's Opinion | 56% Buy | 88% Buy | 40% Buy | ||
| Previous Opinion | 56% Buy | 100% Buy | 40% Buy | ||
| Last Month's Opinion | 88% Buy | 100% Buy | 100% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +10.63% since 04/23/24 | +3.85% since 04/23/24 | -2.58% since 04/23/24 | ||
| Low | 6.47 on 04/25/24 | 3.20 on 04/25/24 | 3.56 on 04/30/24 | ||
| High | 7.98 on 04/30/24 | 3.78 on 04/29/24 | 4.13 on 04/24/24 | ||
| 1-Month | |||||
| %Chg | -1.66% since 03/28/24 | +46.86% since 03/28/24 | -20.46% since 03/28/24 | ||
| Low | 6.47 on 04/25/24 | 2.26 on 04/01/24 | 3.42 on 04/18/24 | ||
| High | 9.68 on 04/08/24 | 4.27 on 04/12/24 | 5.83 on 04/15/24 | ||
| 3-Month | |||||
| %Chg | +38.74% since 01/30/24 | +100.57% since 01/30/24 | +8.02% since 01/30/24 | ||
| Low | 5.08 on 02/05/24 | 1.59 on 02/07/24 | 2.62 on 02/09/24 | ||
| High | 9.86 on 03/22/24 | 4.27 on 04/12/24 | 5.83 on 04/15/24 | ||
| 6-Month | |||||
| %Chg | +38.24% since 10/30/23 | +73.76% since 10/30/23 | +110.61% since 10/30/23 | ||
| Low | 4.00 on 11/28/23 | 1.55 on 12/29/23 | 1.66 on 11/01/23 | ||
| High | 9.86 on 03/22/24 | 4.27 on 04/12/24 | 5.83 on 04/15/24 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 216,942 | 222,854 | 210,897 | ||
| Shares Outstanding, K | 29,396 | 61,904 | 54,921 | ||
| Annual Sales | 80,000 | 0 | 0 | ||
| Annual Net Income | -48,820,000 | -41,070,000 | -121,830,000 | ||
| Last Quarter Sales | 80,000 | 0 | 0 | ||
| Last Quarter Net Income | -9,320,000 | -10,000,000 | -33,080,000 | ||
| 60-Month Beta | 0.01 | 0.84 | 1.51 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.33 on 03/29/24 | -0.16 on 03/29/24 | -0.47 on 02/15/24 | ||
| Latest Earnings Date | 05/20/24 | 05/20/24 | 05/13/24 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 0.00 | 0.00 | ||